Metronidazole-Induced Toxic Encephalopathy in A Hemodialysis Patient: A Case Report |
Ji-Hye Lee, M.D.1, Min-Ok Kim, M.D.1, So-Yeon Choi, M.D.1, Hyun-Ju Choi, M.D.1, Hyun-Jin Kim, M.D.1, Ki-Woon Kang, M.D.1, Jong-Ho Shin, M.D.1 and In-Kyu Yu, M.D.2 |
Department of Internal Medicine1 Department of Radiology2 Eulji University Hospital, Eulji University, Daejeon, Korea |
증례 : Metronidazole-Induced Toxic Encephalopathy in A Hemodialysis Patient: A Case Report |
Ji-Hye Lee, M.D.1, Min-Ok Kim, M.D.1, So-Yeon Choi, M.D.1, Hyun-Ju Choi, M.D.1, Hyun-Jin Kim, M.D.1, Ki-Woon Kang, M.D.1, Jong-Ho Shin, M.D.1 and In-Kyu Yu, M.D.2 |
Department of Internal Medicine1, Department of Radiology2, Eulji University Hospital, Eulji University, Daejeon, Korea |
|
Abstract |
Metronidazole, one of the mainstay drugs for the treatment of anaerobic infections and protozoal infections, may produce some serious neurological side effects. Seizure, peripheral neuropathy, dizziness, vertigo, ataxia, confusion, irritability, headache and tremor have been reported among patients receiving metronidazole, particularly among those receiving high dose of the drug.
However, no specific dose adjustment is recommended for patients with renal or hepatic dysfunction receiving metronidazole because the accumulation of the drug and its metabolites can occur in terms of severity of illness and patient tolerability. Although metronidazole is significantly removed by hemodialysis, no specific dose recommendations are made for this patient population. Recently, we experienced metronidazole-induced encephalopathy in a patient with end-stage renal disease, which was diagnosed by brain magnetic resonance imaging (MRI). Herein, we report a case with a review of literature.
|
Key Words:
Metronidazole, Encephalopathy, Hemodialysis |
|